BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 25103956)

  • 1. Performance of two new automated assays for measuring von Willebrand activity: HemosIL AcuStar and Innovance.
    de Maistre E; Volot F; Mourey G; Aho LS; Ternisien C; Briquel ME; Bertrand MA; Tardy B; Frotscher B; Nguyen P; Dumont L; Vandroux D; Hézard N; Trossaërt M
    Thromb Haemost; 2014 Oct; 112(4):825-30. PubMed ID: 25103956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A two-centre comparative evaluation of new automated assays for von Willebrand factor ristocetin cofactor activity and antigen.
    Stufano F; Lawrie AS; La Marca S; Berbenni C; Baronciani L; Peyvandi F
    Haemophilia; 2014 Jan; 20(1):147-53. PubMed ID: 24028703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of von Willebrand factor (VWF) activity levels determined by HemosIL AcuStar assay and HemosIL LIA assay with ristocetin cofactor assay by aggregometry.
    Sagheer S; Rodgers S; Yacoub O; Dauer R; Mcrae S; Duncan E
    Haemophilia; 2016 May; 22(3):e200-7. PubMed ID: 27076201
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validation of a new panel of automated chemiluminescence assays for von Willebrand factor antigen and activity in the screening for von Willebrand disease.
    Verfaillie CJ; De Witte E; Devreese KM
    Int J Lab Hematol; 2013 Oct; 35(5):555-65. PubMed ID: 23551532
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of an automated method for measuring von Willebrand factor activity in clinical samples without ristocetin.
    Graf L; Moffat KA; Carlino SA; Chan AK; Iorio A; Giulivi A; Hayward CP
    Int J Lab Hematol; 2014 Jun; 36(3):341-51. PubMed ID: 24750681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of a new chemiluminescent immunoassay for von Willebrand factor activity with the ristocetin cofactor-induced platelet agglutination method.
    Cabrera N; Moret A; Caunedo P; Cid AR; Vila V; España F; Aznar JA
    Haemophilia; 2013 Nov; 19(6):920-5. PubMed ID: 23730809
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Towards improved diagnosis of von Willebrand disease: comparative evaluations of several automated von Willebrand factor antigen and activity assays.
    Favaloro EJ; Mohammed S
    Thromb Res; 2014 Dec; 134(6):1292-300. PubMed ID: 25300811
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Screening for von Willebrand disease: contribution of an automated assay for von Willebrand factor activity.
    Lasne D; Dey C; Dautzenberg MD; Cherqaoui Z; Monge F; Aouba A; Torchet MF; Geloen D; Landais P; Rothschild C
    Haemophilia; 2012 May; 18(3):e158-63. PubMed ID: 21951857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of an automated von Willebrand factor activity assay in von Willebrand disease.
    Trossaërt M; Ternisien C; Lefrancois A; Llopis L; Goudemand J; Sigaud M; Fouassier M; Caron C
    Clin Appl Thromb Hemost; 2011; 17(6):E25-9. PubMed ID: 20724302
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of several von Willebrand factor (VWF) activity assays for monitoring patients undergoing treatment with VWF/FVIII concentrates: improved performance with a new modified automated method.
    Hillarp A; Friedman KD; Adcock-Funk D; Tiefenbacher S; Nichols WL; Chen D; Stadler M; Schwartz BA
    Haemophilia; 2015 Nov; 21(6):837-45. PubMed ID: 26172561
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Performance evaluation and multicentre study of a von Willebrand factor activity assay based on GPIb binding in the absence of ristocetin.
    Patzke J; Budde U; Huber A; Méndez A; Muth H; Obser T; Peerschke E; Wilkens M; Schneppenheim R
    Blood Coagul Fibrinolysis; 2014 Dec; 25(8):860-70. PubMed ID: 25192242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rapid assay for ristocetin cofactor activity using an automated coagulometer (ACL 9000).
    Lattuada A; Preda L; Sacchi E; Gallo L; Federici AB; Rossi E
    Blood Coagul Fibrinolysis; 2004 Sep; 15(6):505-11. PubMed ID: 15311161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
    Favaloro EJ; Mohammed S
    Thromb Res; 2016 May; 141():202-11. PubMed ID: 26743192
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of Von Willebrand factor (VWF) activity VWF:Ac with VWF ristocetin cofactor activity VWF:RCo.
    Geisen U; Zieger B; Nakamura L; Weis A; Heinz J; Michiels JJ; Heilmann C
    Thromb Res; 2014 Aug; 134(2):246-50. PubMed ID: 24891215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparative analysis of different automated von Willebrand factor glycoprotein Ib-binding activity assays in well typed von Willebrand disease patients.
    Vangenechten I; Mayger K; Smejkal P; Zapletal O; Michiels JJ; Moore GW; Gadisseur A
    J Thromb Haemost; 2018 Jul; 16(7):1268-1277. PubMed ID: 29742318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative evaluation of a new automated assay for von Willebrand factor activity.
    Lawrie AS; Stufano F; Canciani MT; Mackie IJ; Machin SJ; Peyvandi F
    Haemophilia; 2013 Mar; 19(2):338-42. PubMed ID: 23205618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
    Turecek PL; Siekmann J; Schwarz HP
    Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of an automated platelet-based assay of ristocetin cofactor activity.
    Lawrie AS; Mackie IJ; Machin SJ; Peyvandi F
    Haemophilia; 2011 Mar; 17(2):252-6. PubMed ID: 21070498
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of an automated chemiluminescent assay to a manual ELISA assay for determination of von Willebrand Factor collagen binding activity on VWD plasma patients previously diagnosed through molecular analysis of VWF.
    Jousselme E; Jourdy Y; Rugeri L; Négrier C; Nougier C
    Int J Lab Hematol; 2018 Feb; 40(1):77-83. PubMed ID: 28980759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution multimer analysis and the PFA-100 platelet function analyser can detect von Willebrand disease type 2A without a pathological ratio of ristocetin cofactor activity and von Willebrand antigen level.
    Weiss DR; Strasser EF; Ringwald J; Zimmermann R; Eckstein R
    Clin Lab; 2012; 58(11-12):1203-9. PubMed ID: 23289190
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.